Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 9/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.39 |
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4277446 | 0.98 | PTPN1 (0.41) | PTPN1MAPK1CA2DNMT1PTGS1 | |
| SCHEMBL6939609 | 0.95 | GPR84 (0.43) | PTPN1MAPK1DNMT1PTGS1PTGS2 | |
| SCHEMBL6940135 | 0.93 | GPR84 (0.46) | DNMT1PTGS1PTGS2MGLLFAAH | |
| SCHEMBL1574549 | 0.93 | GPR84 (0.46) | DNMT1PTGS1PTGS2MGLLFAAH | |
| SCHEMBL6934782 | 0.93 | GPR84 (0.46) | DNMT1PTGS1PTGS2MGLLFAAH | |
| SCHEMBL43883 | 0.93 | GPR84 (0.46) | DNMT1PTGS1PTGS2MGLLFAAH | |
| SCHEMBL30634818 | 0.93 | GPR84 (0.46) | DNMT1PTGS1PTGS2MGLLFAAH | |
| Hydrochloric Acid SCHEMBL6934814 | 0.92 | GPR84 (0.44) | DNMT1PTGS1PTGS2MGLLFAAH | |
| SCHEMBL258485 | 0.92 | GPR84 (0.44) | DNMT1PTGS1PTGS2MGLLFAAH | |
| SCHEMBL258604 | 0.92 | GPR84 (0.44) | DNMT1PTGS1PTGS2MGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319171-A1 | COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER | CANCER ADVANCES INC. (US) | 2025-10-16 | — | — | US | claimed |
| US-20250242007-A1 | COMPOSITIONS AND METHODS FOR INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER | CANCER ADVANCES INC. (US) | 2025-07-31 | — | — | US | claimed |
| CN-119912833-A | Asphalt coating material, preparation method thereof and double-base asphalt waterproof coiled material | 河北宇阳泽丽防水材料有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119823209-A | Synthesis method of cyclic peptide containing maleimide acid | 江苏金斯瑞生物科技有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-20250073175-A1 | Intra-Dosage Form Coatings and Applications Thereof | BALCHEM CORPORATION | 2025-03-06 | — | — | US | claimed |
| US-20250042846-A1 | METHOD FOR PREPARING A SULFUR OR SELENISED COMPOUND BY THIOLENE REACTION | ADISSEO FRANCE S.A.S. (FR) | 2025-02-06 | — | — | US | claimed |
| EP-4489731-A2 | INTRA-DOSAGE FORM COATINGS AND APPLICATIONS THEREOF | Balchem Corporation (US) | 2025-01-15 | — | — | EP | claimed |
| CN-119264155-A | Latent curing agent based on dynamic crosslinking-controllable dissolution mechanism | 江南大学 | 2025-01-07 | — | — | CN | claimed |
| CN-119185587-A | Enhanced penetration type dual-response nanoparticle for co-delivering chemotherapeutic drugs and gene drugs, and preparation method and application thereof | 复旦大学 | 2024-12-27 | — | — | CN | claimed |
| WO-2024258015-A1 | METHOD FOR MANUFACTURING HYDROGEL FOR THREE-DIMENSIONAL CELL CULTURE, CAPABLE OF CONTROLLING OXYGEN CONCENTRATION, AND METHOD FOR CONSTRUCTING DISEASE MODEL | 인천대학교 산학협력단 | 2024-12-19 | — | — | WO | claimed |
| WO-2009070640-A2 | METHODS AND COMPOSITIONS FOR AMPLIFYING A DETECTABLE SIGNAL | GREAT BASIN SCIENTIFIC (US) | 2009-06-04 | — | — | WO | claimed |
| US-20090098076-A1 | Method For the Production of a Keratin-Binding Effector Molecule | BASF SE (DE) | 2009-04-16 | — | — | US | claimed |
| JP-2009508852-A | — | — | 2009-03-05 | — | — | JP | claimed |
| US-20080286688-A1 | Photosensitive Resin Composition and Cured Product Thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | claimed |
| EP-1973952-A1 | CONJUGATE COMPRISING PHARMACEUTICAL ACTIVE COMPOUND COVALENTLY BOUND TO MUCOADHESIVE POLYMER AND TRANSMUCOSAL DELIVERY METHOD OF PHARMACEUTICAL ACTIVE COMPOUND USING THE SAME | Gwangju Institute of Science and Technology (KR) | 2008-10-01 | — | — | EP | claimed |
| WO-2008049643-A2 | GD2 PEPTIDE MIMOTOPES FOR ANTICANCER VACCINATION | CHARITE - UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2008-05-02 | — | — | WO | claimed |
| WO-2007083984-A1 | CONJUGATE COMPRISING PHARMACEUTICAL ACTIVE COMPOUND COVALENTLY BOUND TO MUCOADHESIVE POLYMER AND TRANSMUCOSAL DELIVERY METHOD OF PHARMACEUTICAL ACTIVE COMPOUND USING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2007-07-26 | — | — | WO | claimed |
| EP-1710626-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND CURED PRODUCT THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2006-10-11 | — | — | EP | claimed |
| EP-0665020-A2 | Method for preparing thioether conjugates | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-08-02 | — | — | EP | claimed |
| US-5073611-A | Containing photoreactive compound capable of abstracting hydrogen; coatings, hot melt adhesives | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042846-A1 | METHOD FOR PREPARING A SULFUR OR SELENISED COMPOUND BY THIOLENE REACTION | SCLY, TST, SELENOI | PTPN1 3784/4885MAPK1 1805/4885CA2 3289/4885 |
| US-20090098076-A1 | Method For the Production of a Keratin-Binding Effector Molecule | KRT18, KRTCAP2, CUTA | PTPN1 4276/4885MAPK1 3547/4885CA2 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.